Star Health and Allied Insurance Company Ltd.

NSE: STARHEALTH | BSE: 543412

Mid-range Performer

Download real time

458.20 -2.00 (-0.43%)

39.99% Gain from 52W Low

171.6K NSE+BSE Volume

NSE 24 Dec, 2025 11:19 AM (IST)

26,927.5

Market Cap

Below industry Median

Beta 1Year

Very Low volatility

Star Health and Allied Insurance Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for STARHEALTH, BSE:543412 Star Health and Allied Insurance Company Ltd.

Search Inside the pdf :

Star Health and Allied Insurance Company Ltd.

06 Nov 2025

458.20

-0.43%

Volume/loss ratio improvement key positives; managing GST cost impact will be vital

Buy: Star Health and Allied Ins...

Target

ICICI Securities Limited

We believe Star Health (Star) is on a steady earnings growth trajectory driven by better incremental balance between volume growth and profitability, as witnessed in its H1FY26 result (13.1% YoY growth in GEP, while IFRS PAT grew 20.9% YoY).

Star Health and Allied Insurance Company Ltd. is trading below its 30 day SMA of 481.6

Star Health and Allied Insurance Company Ltd.

29 Oct 2025

458.20

-0.43%

Loss ratio improves; strong growth in fresh business

Buy: Star Health and Allied Ins...

Target

Motilal Oswal

Star Health (STARHEAL)’s net earned premium grew 10% YoY to INR40.8b (in-line) in 2QFY26. For 1HFY26, NEP grew 11% YoY to INR80b.

Star Health and Allied Insurance Company Ltd. is trading below its 30 day SMA of 481.6

Star Health and Allied Insurance Company Ltd.

03 Sep 2025

458.20

-0.43%

Available earning levers make risk-reward attractive

Buy: Star Health and Allied Ins...

Target

ICICI Securities Limited

We believe Star Health (Star) is on a steady earnings growth trajectory driven by better incremental balance between volume growth and profitability, as witnessed in its Q1FY26 result (14% YoY growth in GEP while IFRS PAT grew 44% YoY).

Star Health and Alli.. has an average target of 521.50 from 4 brokers.

Star Health and Allied Insurance Company Ltd.

25 Aug 2025

458.20

-0.43%

Navigating growth with caution

Buy: Star Health and Allied Ins...

Motilal Oswal

Star Health (STARHEAL) has reported lower growth than its SAHI peers, which has led to market share loss for the company in the health segment to 11.4% (YTDFY26) vs. 15.7% in FY21.

Star Health and Allied Insurance Company Ltd. is trading above its 200 day SMA of 436.9

Star Health and Allied Insurance Company Ltd.

30 Jul 2025

458.20

-0.43%

In-line underwriting performance

Buy: Star Health and Allied Ins...

Target

Motilal Oswal

Star Health’s (STARHEAL) net earned premium rose 12% YoY to INR39.4b (in line) during 1QFY26. Claims ratio at 69.5% (in line) grew 190bp YoY, driven by a 15% YoY increase in net claims incurred to INR27.4b (in line).

Star Health and Alli.. has an average target of 521.50 from 4 brokers.

Star Health and Allied Insurance Company Ltd.

14 May 2025

458.20

-0.43%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Hold: Star Health and Allied Ins...

Target

Geojit BNP Paribas

The company is currently facing challenges due to the new accounting standards and a surge in claim frequency and severity, which are affecting its profitability. However, recent price adjustments are expected to mitigate the impact of rising medical costs and hospitalisation trends, potentially leading to a gradual decline in the claims ratio over the next few quarters. A potential reduction in expense ratios and stable commission ratios are expected as the company grows. Additionally, the company is adopting a targeted approach by focusing on specific market segments...

Star Health and Allied Insurance Company Ltd. is trading below its 30 day SMA of 481.6

Star Health and Allied Insurance Company Ltd.

13 Feb 2025

458.20

-0.43%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Hold: Star Health and Allied Ins...

Recommendation Target

Geojit BNP Paribas

Star Health and Alli.. has an average target of 521.50 from 4 brokers.

Star Health and Allied Insurance Company Ltd.

30 Jan 2025

458.20

-0.43%

Arduous journey toward gradual recovery in claims ratio

Buy: Star Health and Allied Ins...

Recommendation

Emkay

Star Health reported weak performance for Q3FY25, with GWP growth at 5.3% (at a 1.8% miss) impacted by implementation of the 1/n regulation and Combined Ratio at 103.3% vs our estimate of 100.5% driven by higher Claims and Expense Ratio (affected by 1/n premium accounting of long-term policies).